ストックスクリーナーアプリを入手
14.61
1.65%
-0.2472
Aurinia Pharmaceuticals Inc (AUPH) 最新ニュース
Does Aurinia Pharmaceuticals Inc. offer margin of safetyJuly 2025 Big Picture & Safe Capital Investment Plans - mfd.ru
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Ritholtz Wealth Management Buys Shares of 84,515 Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Aug Rallies: Will Aurinia Pharmaceuticals Inc benefit from government policyQuarterly Earnings Report & Daily Growth Stock Investment Tips - baoquankhu1.vn
Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - sharewise.com
Aurinia downgraded at RBC on risk-reward setup - MSN
How Investors May Respond To Aurinia Pharmaceuticals (AUPH) Expanding Autoimmune Pipeline And Deepening Otsuka Collaboration - Sahm
Trading the Move, Not the Narrative: (AUPH) Edition - Stock Traders Daily
Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: 9.08% Potential Upside Amid Promising Biotech Innovations - DirectorsTalk Interviews
With 54% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns - Yahoo Finance
How Aurinia Pharmaceuticals Inc. stock responds to policy changesWeekly Earnings Recap & Growth Focused Entry Point Reports - ulpravda.ru
Aurinia Pharmaceuticals (NASDAQ:AUPH) Share Price Passes Above 50-Day Moving AverageHere's Why - MarketBeat
How strong is Aurinia Pharmaceuticals Inc. stock balance sheetJuly 2025 Patterns & Growth Oriented Trade Recommendations - ulpravda.ru
Is Aurinia Pharmaceuticals Inc. stock a top pick in earnings seasonTrade Analysis Report & Precise Swing Trade Entry Alerts - ulpravda.ru
Earnings Report: Why Aurinia Pharmaceuticals Inc. (IKAP) stock stays resilientProfit Target & Weekly Top Gainers Trade List - Улправда
Is Aurinia Pharmaceuticals Inc. (IKAP) stock resilient in recession scenarios2025 Technical Patterns & Low Risk High Reward Ideas - Улправда
Why Aurinia Pharmaceuticals Inc. (IKAP) stock is listed among top recommendationsPortfolio Update Summary & Stock Timing and Entry Methods - Улправда
Why retail investors favor Aurinia Pharmaceuticals Inc. stockSupport Zone Identification & Free High Yield Growth Strategies - Улправда
Aruinia discloses FDA information request on Lupkynis amid top regulator’s exit - MSN
Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Riding the Biotech Wave with 8.93% Potential Upside - DirectorsTalk Interviews
RBC Capital Downgrades Aurinia Pharmaceuticals (AUPH) - MSN
Aug Sectors: Why retail investors favor Aurinia Pharmaceuticals Inc. stockTrade Entry Report & Smart Swing Trading Alerts - moha.gov.vn
Aurinia Pharmaceuticals IncCommon Shares (NQ: AUPH - FinancialContent
(AUPH) Volatility Zones as Tactical Triggers - Stock Traders Daily
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Down 3.6%Here's Why - MarketBeat
Aurinia Pharmaceuticals (AUPH) Price Target Increased by 34.15% to 16.03 - MSN
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Is a Favorite Amongst Institutional Investors Who Own 54% - 富途牛牛
Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Biotech Contender with a 4.89% Upside - DirectorsTalk Interviews
Spoke.comAurinia Pharmaceuticals IncCommon Shares (Nasdaq:AUPH) Stock Quote - FinancialContent
Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - AOL.com
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Is Aurinia Pharmaceuticals (AUPH) Outperforming Other Medical Stocks This Year? - sharewise.com
Aurinia Pharmaceuticals (NASDAQ:AUPH) rises 3.1% this week, taking three-year gains to 292% - simplywall.st
Understanding the Setup: (AUPH) and Scalable Risk - Stock Traders Daily
How Aurinia Pharmaceuticals Inc. (IKAP) stock trades pre earningsDebt-to-Equity Ratio Analysis & Watch and Learn From Live Trades - bollywoodhelpline.com
Aurinia Pharmaceuticals stock hits 52-week high at 16.49 USD By Investing.com - Investing.com Australia
Aurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 12-Month HighHere's Why - MarketBeat
Aurinia Pharmaceuticals stock hits 52-week high at 16.49 USD - Investing.com
Why Aurinia Pharmaceuticals Inc. (IKAP) stock gets analyst attentionWeekly Market Outlook & Stock Timing and Entry Methods - Улправда
Chart Watch: Will Aurinia Pharmaceuticals Inc. stock pay special dividendsWall Street Watch & Free Risk Controlled Daily Trade Plans - Улправда
Will Aurinia Pharmaceuticals Inc. stock outperform international peersWeekly Stock Recap & Weekly High Return Stock Opportunities - Bölüm Sonu Canavarı
Is Aurinia Pharmaceuticals Inc. stock supported by innovation pipelineJuly 2025 Sector Moves & Community Verified Watchlist Alerts - DonanımHaber
Is Aurinia Pharmaceuticals Inc. (IKAP) stock undervalued after correction2025 Buyback Activity & Smart Swing Trading Techniques - DonanımHaber
Will Aurinia Pharmaceuticals Inc. stock benefit from automationPortfolio Value Report & Proven Capital Preservation Methods - DonanımHaber
Aurinia Pharmaceuticals: Silencing Doubters, But Competition Looms (NASDAQ:AUPH) - Seeking Alpha
Aurinia Pharmaceuticals Inc $AUPH Shares Purchased by Squarepoint Ops LLC - MarketBeat
Marex Group plc Buys Shares of 135,000 Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
2.77%
2.45%
大文字化:
|
ボリューム (24 時間):